The Pharma Perspective

In this episode of The Pharma Perspective podcast, Grant Coren, life science recruiter with over 30 years of experience and founder of his own executive search practice, discusses the state of the pharma job market in 2026, why hiring has slowed across pharma, biotech, and CRO alike, how AI screening tools and applicant tracking systems are changing — and distorting — the recruitment process, why...

In this episode of The Pharma Perspective podcast, Jerry Avorn , Professor of Medicine at Harvard Medical School and author of "Rethinking Medications," discusses the state of drug regulation in the United States, the problems with accelerated approvals and missing confirmatory trials, how academic detailing can change prescribing behavior more effectively than guidelines, the misuse of surrogate...

In this episode of The Pharma Perspective podcast, Katja Rüdell , one of the world's leading clinical outcome assessment and patient-reported outcomes experts, discusses the role of PROs in drug development, regulatory expectations from FDA and EMA for outcome measure validation, the challenges of developing fit-for-purpose COA instruments, the evolution of patient-centred research in pharmaceutic...

In this episode of The Pharma Perspective podcast, Jack Neill-Hall from the Association of the British Pharmaceutical Industry (ABPI) discusses the UK pharmaceutical pricing environment, NICE's cost-effectiveness threshold and appraisal process for NHS medicines, industry transparency through the Code of Practice and Disclosure UK, healthcare budget allocation, and why some medicines never reach U...

In this episode of " The Pharma Perspective ", I speak with Karl Claxton , Professor of Economics at the University of York and founding NICE Appraisal Committee member, about his open letter to the UK Prime Minister on pharmaceutical pricing for branded medicines, why raising the NICE willingness-to-pay threshold would be catastrophic for NHS patients, and his proposals for fundamentally reformin...

Join me in my discussion with Barinder Singh , Founder of PharmacoEvidence, who quit his stable HEOR job in 2020—amid a pandemic and with a baby on the way—to start his own consultancy. In this episode of The Pharma Perspective , we explore how that bold decision turned into a thriving 40+ person company leading NICE submissions with AI-validated methods. We also talk about what it really takes to...

Join me in my discussion with Peter Wickersham , Pharma Vice President & General Manager with 25+ years of experience, as we explore leadership, career growth, and navigating the evolving pharma industry in the age of AI. In this episode of Pharma Perspectives , Peter shares his insights on the challenges and opportunities shaping pharma today, offering practical advice for professionals intereste...